THE COMBINATION THERAPY MODEL OF Andrographis paniculata EXTRACT AND CHLOROQUINE ON Plasmodium berghei INFECTED MICE
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2015, Vol 8, Issue 2
Abstract
 Objective: The aim was to determine the antimalarial drug effectiveness of the combination therapy model of 80% ethanolic extract of sambiloto (EES)and chloroquine on Plasmodium berghei infected mice.Methods: Five groups of P. berghei infected mice were used in this study, divided by three combinations therapy models of EES and chloroquinegroups (Model A, B, C), one monotherapy of EES group (Model D) and one untreated group (Model E) as a control. EES and chloroquine were usedat a dose of 100 mg/kg mice body weight and 0.15 mg/kg mice body weight, respectively. Only for Model C, chloroquine was used at a dose of10 mg/kg mice body weight. Three combinations therapy models consisted of Model A: Infected mice treated by EES and chloroquine for 4 days;Model B: treated by EES for 4 days and chloroquine for 1 day at 1st day; Model C: treated by EES for 4 days and chloroquine for 1 day at 4th day.Meanwhile, Model D and E were treated by EES and vehicle each for 4 days, respectively. Blood smear of all mice was prepared with Giemsa stain.Antimalarial activity was determined by the difference between the mean value of parasitemia of control (Model E, taken as 100%) and those of theexperimental group (Model A, B, C and D).Results: Three combination therapy models (Model A, B, C) and one monotherapy (Model D) were showed antimalarial activities against parasitewith inhibition of parasite growth by 85.61%, 69.31%, 73.64% and 65.14%, respectively.Conclusion: Model A was showed as the most effective combination therapy model on mice infected by malaria. The results indicated that combinationtherapy model of EES and chloroquine were able to increase the antimalarial effectiveness by 85.61% inhibition of parasite growth and having smallerrisk of resistance by using low dose of chloroquine (0.15 mg/kg mice body weight).Keywords: Antimalarial combination therapy, Andrographis paniculata, Chloroquine.
Authors and Affiliations
Achmad Fuad Hafid
RELATED SUBSTANCE METHOD DEVELOPMENT AND VALIDATION OF LOXAPINE SUCCINATE IN CAPSULE DOSAGE FORM BY REVERSE PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Objective: The present study gives a simple, rapid, and accurate stability indicating reverse phase high-performance liquid chromatography method for the determination of loxapine succinate and its related substance (rel...
A PROSPECTIVE STUDY ON GERIATRIC PRESCRIBING PATTERN AND MEDICATION ADHERENCE IN A TERTIARY CARE HOSPITAL
  Objectives: To identify potentially inappropriate medications (PIMs) using Beers criteria 2015 and to recommend safer alternative medication for the above. To assess the medication adherence in geriatric patients and...
PERFORMANCE ANALYSIS USING CODE CONVERTER APPROACH AND THE APPLICATION OF APPROXIMATE ENTROPY AS POST CLASSIFIER FOR THE CLASSIFICATION OF EPILEPSY RISK LEVELS FROM EEG SIGNALS
ABSTRACTObjective: The electroencephalogram (EEG) is actually a measure of the cumulative firing of neurons in various parts of the brain. The EEG containsthe information with regard to the changes in the electrical pote...
ALZHEIMER’S DISEASE: A CONSEQUENCE OF IMPAIRED MITOPHAGY?
Neurodegenerative disorders involve complexities of the pathologies, characterized by the progressive loss of neuronal viability, leading to severe physical and cognitive impairments in affected patients. These disorders...
PROTECTIVE EFFECT OF SYNTHETIC ANTIOXIDANTS AND ETHANOLIC EXTRACT OF BACOPA MONNIERI AGAINST LEAD TOXICITY INDUCED METABOLIC DYSFUNCTIONS IN MICE BRAIN AND LIVER HOMOGENATES: AN IN VITRO APPROACH
Objective: The main objective of the present study was to investigate the ameliorative potential of synthetic antioxidants mixture comprising N-acetyl cysteine, ascorbic acid, tocopheryl acetate, and thiamine as micronut...